ReviewFrontiers in immunology2024

Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy.

Ali Zarezadeh Mehrabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.